Literature DB >> 21691207

Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry.

Michael A Campitelli1, Anna M Chiarelli, Lucia Mirea, Lindsay Stewart, Gord Glendon, Paul Ritvo, Irene L Andrulis, Julia A Knight.   

Abstract

This study compares adherence to breast and ovarian cancer screening recommendations among a population cohort of women at familial risk of breast and/or ovarian cancer. This cross-sectional study included 1039 first-degree female relatives without breast cancer identified from the Ontario site of the Breast Cancer Family Registry. We compared breast and ovarian cancer screening behaviors, using a telephone-administered questionnaire among three groups of women defined by their familial risk (high, moderate, and low) of breast and/or ovarian cancer. Associations between screening behaviors and familial risk were assessed using multinomial regression models adjusted by familial clustering. Women, 40-49 years of age, at moderate or high familial risk were significantly more likely to have had a screening mammogram within the past 12 months [odds ratio (OR): 2.80; 95% confidence interval (CI): 1.40-5.58], and women of less than 50 years of age were more likely to have a clinical breast examination (OR: 1.84; 95% CI: 1.02-3.31) compared with women at low familial risk. Compared with women at low or moderate familial risk, women at high familial risk were significantly more likely to have ever had a genetic test for the BRCA 1/2 genes (OR: 2.67; 95% CI: 1.76-4.05). Although the overall level of adherence among high-risk women is suboptimal in the community, women at a higher familial risk are adhering more often to cancer screening recommendations than women at a lower familial risk.

Entities:  

Mesh:

Year:  2011        PMID: 21691207      PMCID: PMC3179806          DOI: 10.1097/CEJ.0b013e3283476217

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  43 in total

1.  Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review.

Authors:  Maria C Katapodi; Kathy A Lee; Noreen C Facione; Marylin J Dodd
Journal:  Prev Med       Date:  2004-04       Impact factor: 4.018

Review 2.  Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history.

Authors:  Harvey J Murff; David R Spigel; Sapna Syngal
Journal:  JAMA       Date:  2004-09-22       Impact factor: 56.272

3.  Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Linda L Humphrey; Mark Helfand; Benjamin K S Chan; Steven H Woolf
Journal:  Ann Intern Med       Date:  2002-09-03       Impact factor: 25.391

4.  Positive predictive value of screening mammography by age and family history of breast cancer.

Authors:  K Kerlikowske; D Grady; J Barclay; E A Sickles; A Eaton; V Ernster
Journal:  JAMA       Date:  1993-11-24       Impact factor: 56.272

5.  Breast screening outcomes in women with and without a family history of breast and/or ovarian cancer.

Authors:  E E Halapy; A M Chiarelli; N Klar; J Knight
Journal:  J Med Screen       Date:  2004       Impact factor: 2.136

6.  Concordance of self-reported data and medical record audit for six cancer screening procedures.

Authors:  N P Gordon; R A Hiatt; D I Lampert
Journal:  J Natl Cancer Inst       Date:  1993-04-07       Impact factor: 13.506

7.  Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations.

Authors:  Thomas M Kolb; Jacob Lichy; Jeffrey H Newhouse
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

8.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

Authors:  Ellen Warner; Donald B Plewes; Kimberley A Hill; Petrina A Causer; Judit T Zubovits; Roberta A Jong; Margaret R Cutrara; Gerrit DeBoer; Martin J Yaffe; Sandra J Messner; Wendy S Meschino; Cameron A Piron; Steven A Narod
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

9.  Measuring the use of mammography: two methods compared.

Authors:  D Degnan; R Harris; J Ranney; D Quade; J A Earp; J Gonzalez
Journal:  Am J Public Health       Date:  1992-10       Impact factor: 9.308

10.  The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.

Authors:  Esther M John; John L Hopper; Jeanne C Beck; Julia A Knight; Susan L Neuhausen; Ruby T Senie; Argyrios Ziogas; Irene L Andrulis; Hoda Anton-Culver; Norman Boyd; Saundra S Buys; Mary B Daly; Frances P O'Malley; Regina M Santella; Melissa C Southey; Vickie L Venne; Deon J Venter; Dee W West; Alice S Whittemore; Daniela Seminara
Journal:  Breast Cancer Res       Date:  2004-05-19       Impact factor: 6.466

View more
  11 in total

1.  Screening magnetic resonance imaging recommendations and outcomes in patients at high risk for breast cancer.

Authors:  Sima Ehsani; Roberta M Strigel; Erica Pettke; Lee Wilke; Amye J Tevaarwerk; Wendy B DeMartini; Kari B Wisinski
Journal:  Breast J       Date:  2015-03-17       Impact factor: 2.431

2.  What Matters to Women When Making Decisions About Breast Cancer Chemoprevention?

Authors:  Kathryn A Martinez; Angela Fagerlin; Holly O Witteman; Christine Holmberg; Sarah T Hawley
Journal:  Patient       Date:  2016-04       Impact factor: 3.883

3.  Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.

Authors:  Meghan J Walker; Lucia Mirea; Kristine Cooper; Mitra Nabavi; Gord Glendon; Irene L Andrulis; Julia A Knight; Frances P O'Malley; Anna M Chiarelli
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

4.  Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the breast cancer family registry.

Authors:  Meghan J Walker; Lucia Mirea; Gord Glendon; Paul Ritvo; Irene L Andrulis; Julia A Knight; Anna M Chiarelli
Journal:  Breast       Date:  2014-05-10       Impact factor: 4.380

5.  Breast Cancer Screening Behaviors of First Degree Relatives of Women Receiving Breast Cancer Treatment and the Affecting Factors.

Authors:  Nurcan Kırca; Ayla Tuzcu; Sebahat Gözüm
Journal:  Eur J Breast Health       Date:  2018-01-01

6.  The Association Between Periodontal Disease and Breast Cancer in a Prospective Cohort Study.

Authors:  Mengmeng Jia; Zeni Wu; Emily Vogtmann; Katie M O'Brien; Clarice R Weinberg; Dale P Sandler; Gretchen L Gierach
Journal:  Cancer Prev Res (Phila)       Date:  2020-07-29

7.  The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry.

Authors:  Ann J Cloud; Ashley Thai; Yuyan Liao; Mary Beth Terry
Journal:  Breast Cancer Res Treat       Date:  2015-01-21       Impact factor: 4.872

8.  Age at initiation of screening mammography by family history of breast cancer in the breast cancer surveillance consortium.

Authors:  Danielle D Durham; Megan C Roberts; Carly P Khan; Linn A Abraham; Robert A Smith; Karla Kerlikowske; Diana L Miglioretti
Journal:  Cancer Causes Control       Date:  2020-10-24       Impact factor: 2.506

9.  Worry is good for breast cancer screening: a study of female relatives from the ontario site of the breast cancer family registry.

Authors:  Li Rita Zhang; Anna M Chiarelli; Gord Glendon; Lucia Mirea; Julia A Knight; Irene L Andrulis; Paul Ritvo
Journal:  J Cancer Epidemiol       Date:  2012-06-28

10.  Accuracy of Self-Reported Screening Mammography Use: Examining Recall among Female Relatives from the Ontario Site of the Breast Cancer Family Registry.

Authors:  Meghan J Walker; Anna M Chiarelli; Lucia Mirea; Gord Glendon; Paul Ritvo; Irene L Andrulis; Julia A Knight
Journal:  ISRN Oncol       Date:  2013-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.